CREDIT SUISSE AG/ - SERES THERAPEUTICS INC ownership

SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 132 filers reported holding SERES THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of SERES THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$326,955
-60.0%
137,376
-19.6%
0.00%
-100.0%
Q2 2023$818,046
+17.5%
170,782
+39.1%
0.00%0.0%
Q1 2023$696,220
+1.3%
122,790
+0.0%
0.00%0.0%
Q4 2022$687,473
-8.2%
122,763
+5.3%
0.00%0.0%
Q3 2022$749,000
+142.4%
116,619
+29.1%
0.00%
Q2 2022$309,000
-50.0%
90,359
+4.1%
0.00%
-100.0%
Q1 2022$618,000
-10.7%
86,827
+4.5%
0.00%
Q4 2021$692,000
+114.2%
83,053
+78.8%
0.00%
Q3 2021$323,000
-68.3%
46,454
+8.5%
0.00%
-100.0%
Q2 2021$1,020,000
+3.3%
42,810
-10.7%
0.00%0.0%
Q1 2021$987,000
-65.4%
47,913
-58.9%
0.00%0.0%
Q4 2020$2,854,000
+2670.9%
116,518
+727.6%
0.00%
Q1 2018$103,000
-2.8%
14,079
+34.3%
0.00%
Q4 2017$106,000
-68.3%
10,483
-49.8%
0.00%
Q3 2017$334,000
+163.0%
20,867
+85.4%
0.00%
Q2 2017$127,000
-54.5%
11,253
-59.9%
0.00%
Q4 2016$279,000
-12.0%
28,096
+9.2%
0.00%
Q3 2016$317,000
-31.8%
25,731
+60.8%
0.00%
-100.0%
Q2 2016$465,000
+83.1%
16,001
+66.7%
0.00%
Q1 2016$254,000
-16.2%
9,596
+11.1%
0.00%
Q4 2015$303,000
-65.0%
8,639
-70.4%
0.00%
-100.0%
Q3 2015$865,00029,1780.00%
Other shareholders
SERES THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 23,117,045$110,730,6464.94%
Lion Point Capital, LP 691,803$3,313,7361.50%
Eversept Partners, LP 3,076,756$14,737,6611.23%
Soleus Capital Management, L.P. 2,045,983$9,800,2591.09%
Knott David M Jr 470,000$2,2510.90%
GREAT POINT PARTNERS LLC 938,067$4,493,3410.88%
Simplify Asset Management Inc. 550,626$2,637,4990.35%
Delphia (USA) Inc. 33,913$162,4430.26%
Alpha DNA Investment Management LLC 138,536$663,5870.22%
Avoro Capital Advisors LLC 2,500,000$11,975,0000.16%
View complete list of SERES THERAPEUTICS INC shareholders